Von Hoff, D D <br/><br/>
Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin.  [electronic resource] 

 -  Seminars in oncology  Sep 1986 
 - 72-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Doxorubicin--administration & dosage<br/>Drug Evaluation<br/>Humans<br/>Interferon Type I--administration & dosage<br/>Neoplasms--therapy<br/>Recombinant Proteins--administration & dosage<br/>Tumor Stem Cell Assay